Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer

Gynecologic Oncology

Volumn 116, Issue 3, 2010, Pages 489-496

  Tsolakidis, D ^a   Amant, F ^a   Van Gorp, T ^a   Leunen, K ^a   Neven, P ^a   Vergote, I ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Coagulation; Diaphragm; Ovarian cancer; Ovarian neoplasms; Primary debulking; Resection; Stripping; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; PACLITAXEL;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DIAPHRAGM DISEASE; DIAPHRAGM MUSCLE; DIAPHRAGMATIC SURGERY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG SURGERY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORBIDITY; MULTIPLE CYCLE TREATMENT; OVARY CANCER; OVERALL SURVIVAL; PLEURA; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; THORACOCENTESIS; TREATMENT OUTCOME; TUBE;

ADULT; AGED; DIAPHRAGM; DISEASE-FREE SURVIVAL; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 75749104959     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.07.014     Document Type: Article

References (46)

1. Meigs J.V. Tumors of the Female Pelvic Organs (1934), MacMillan, New York
2. Griffiths C.T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl. Cancer Inst. Monogr. 42 (1975) 101-104
3. Berek J., Trope C., and Vergote I. Surgery during chemotherapy and at relapse of ovarian cancer. Ann. Oncol. 10 (1999) 87-92
4. Tan D.S., Agarwal R., and Kaye S.B. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 7 11 (2006) 925-934
5. Cliby W., Dowdy S., Feitoza S., Gostout B., and Podratz K. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol. Oncol. 94 (2004) 655-660
6. Griffiths C., and Finkler N. Surgery for carcinoma of ovary: extrapelvic cytoreduction. In: Coppleson M. (Ed). Gynecologic Oncology. 2nd ed. (1992), Churchill Livingstone, London 1325-1333
7. Eisenkop S., and Spirtos N. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer. Gynecol. Oncol. 82 (2001) 489-497
8. Zivanovic O., Eisenhauer E., Zhou Q., Iasonos A., Sabbatini P., Sonoda Y., et al. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecol. Oncol. 108 (2008) 287-292
9. Aletti G., Dowdy S., Podratz K., and Cliby W. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol. Oncol. (2006) 283-287
10. Vergote I., De Wever I., Decloedt J., Tjalma W., Van Gramberen M., and Van Dam P. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer. Semin. Oncol. 27 3 (2000) 31-36
11. Vergote I., Van Gorp T., Amant F., Neven P., and Berteloot P. Neoadjuvant chemotherapy for ovarian cancer. Oncology 19 12 (2005) 1615-1622
12. FIGO system. Staging announcement: FIGO Cancer Committee. Gynecol. Oncol. 25 (1986) 383-385
13. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J. Clin. Oncol. 20 5 (2002) 1248-1259 1
14. Wimberger P., Lehmann N., Kimmig R., Burges A., Meier W., Du Bois A., and Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol. Oncol. 106 1 (2007) 69-74
15. Eisenhauer E., and Chi D. Liver mobilization and diaphragm peritonectomy/resection. Gynecol. Oncol. 104 (2007) S25-S28
16. Vergote I., Van Gorp T., and Devi U.K. Surgery in advanced ovarian cancer. In: Vergote I., and Devi U.K. (Eds). Atlas of Gynaecological Cancer Surgery. 1st ed. (2008) 177-207 Jaypee
17. Silver D. Full-thickness diaphragmatic resection with sample and secure closure to accomplish complete cytoreductive surgery for patients with ovarian cancer. Gynecol. Oncol. 95 (2004) 384-387
18. Eisenhauer E., D'Angelica M., Nadeem R., Sonoda Y., Jarnagin W., Barakat R., et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecol. Oncol. 103 (2006) 871-877
19. Chassagne D., Sismondi P., Horiot J.C., Sinistrero G., Bey P., Zola P., et al. A glossary for reporting complications of gynaecological cancers. Radiother. Oncol. 26 3 (1993) 195-202
20. Common Toxicity Criteria CTC-Version 2.0. www.ctep.cancer.gov/protocol Development/electronic applications/ctc.htm.
21. MEDLOG for windows version 2004-6. www.medlog.com
22. Rustin G.J., Quinn M., Thigpen T., du Bois A., Pujade-Lauraine E., Jakobsen A., et al. Re: new guidelines to evaluate the response to treatment in solid tumors (ovarian cancer). J. Natl. Cancer Inst. 96 (2004) 487-488
23. Vergote I., Marquette S., Amant F., Barteloot P., and Neven P. Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. Int. J. Gynecol. Cancer 15 (2005) 776-779
24. Decloedt J., Berteloot P., and Vergote I. The feasibility of open laparoscopy in gynecologic-oncologic patients. Gynecol. Oncol. 66 1 (1997) 138-140
25. Zang R.Y., Zhang Z.Y., Cai S.M., Li Z.T., Chen J., Tang M.Q., et al. Cytoreductive surgery for stage IV epithelial ovarian cancer. J. Exp. Clin. Cancer Res. 18 4 (1999 Dec) 449-454
26. Akahira J.I., Yoshikawa H., Shimizu Y., Tsunematsu R., Hirakawa T., Kuramoto H., et al. Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study. Gynecol. Oncol. 81 (2001) 398-403
27. Naik R., Nordin A., Cross P.A., Hemming D., de Barros Lopes A., and Monaghan J.M. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases. Gynecol. Oncol. 78 (2000) 171-175
28. Vergote I., De Wever I., Tjalma W., Van Gramberen M., Decloedt J., and van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol. Oncol. 71 3 (1998) 431-436
29. Hoskins W. Epithelial ovarian carcinoma: principles of primary surgery. Gynecol. Oncol. 55 (1994) S91-S96
30. Chi D., Eisenhauer E., Land J., Haddad L., Abu-Rustum N., Sonoda Y., et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecol. Oncol. 103 (2006) 559-564
31. Rosenoff S., Young R., and Chabreu B. Use of peritoneoscopy for initial staging and post therapy evaluation of patients with ovarian cancer. Natl. Canc. Inst. Monogr. 42 (1975) 81-86
32. Hoskins W., Bundy B., Thigpen J., and Omura G. The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol. Oncol. 47 (1992) 167-171
33. Potter M., Partridge E., Hatch K., Soong S., Austin J., and Shingelton H. Primary surgical therapy for ovarian cancer: how much and when. Gynecol. Oncol. 40 (1992) 195-200
34. Eisenkop S, Spirtos N, Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with "biological aggressiveness" and survival? 2001;82:435-41.
35. Eisenkop S., Friedman R., and Wang H. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol. Oncol. 69 (1998) 103-108
36. Kapnick J., Griffiths T., and Finkler N. Occult pleural involvement in stage III ovarian carcinoma: role of diaphragm resection. Gynecol. Oncol. 39 (1990) 135-138
37. Spirtos N, Gross G, Freddo J, Ballon S, Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. 1995;56:345-52
38. Dowdy S., Loewen R., Alleti G., Feitoza S., and Cliby W. Assessment of outcomes and mobility following diaphragmatic peritonectomy for women with ovarian carcinoma. Gynecol. Oncol. 109 (2008) 303-307
39. Meigs J., Armstrond S., and Hamilton H. A further contribution to the syndrome of fibroma of the ovary with fluid in the abdomen and chest, Meigs' syndrome. Am. J. Obstet. Gynecol. 46 (1943) 19-37
40. Lieberman F., and Peters R. Cirrhotic hydrothorax. Further evidence that an acquired diaphragmatic defect is at fault. Arch. Intern. Med. 125 (1970) 114-117
41. Hartz R., Bomalaski J., LoCicero III J., and Murphy R. Pleural ascites without abdominal fluid: surgical considerations. J. Thorac. Cardiovasc. Surg. 87 (1984) 141-143
42. Eisenhauer E., Abu-Rustum N., Sonoda Y., Levine D., Poynor E., Aghajanian C., et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol. Oncol. 103 (2006) 1083-1090
43. Chi D., Franklin C., Levine D., Akselrod F., Sabbatini P., Jarnagin W., et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach. Gynecol. Oncol. 94 (2004) 650-654
44. Montz F., Schlaerth J., and Berek J. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery of ovarian cancer. Gynecol. Oncol. 35 (1989) 338-340
45. Fiorica J., Hoffman M., La Polla J., Roberts W., and Cavanagh D. The management of diaphragmatic lesions in ovarian carcinoma. Obstet. Gynecol. 74 (1989) 927-929
46. Eisenkop S.M., Spirtos N.M., Friedman R.L., Lin W.M., Pisani A.L., and Pertucucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol. Oncol. 20 (2006) 390-396